Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
SBTX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
+207%
0.72
vs -0.67
Q1.23
N/A
-0.00
vs -0.70
Q2.23
N/A
-0.00
vs -0.55
Q3.23
N/A
-0.00
vs -0.50
Q4.23
N/A
NA
vs 0.72
Q1.24
N/A
NA
vs -0.00
Q2.24
N/A
NA
vs -0.00
Q3.24
N/A
NA
vs -0.00
Q4.24
N/A
NA
vs NA
Q1.25
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q4.22
-275%
-1316000.00 vs 754K
Q1.23
-97%
20K vs 663K
Q2.23
-98%
10K vs 464K
Q3.23
-100%
NA vs 189K
Q4.23
+98%
-30000.00 vs -1316000
Q1.24
-100%
NA vs 20K
Q2.24
+4900%
500K vs 10K
Q3.24
NA
2.1M vs NA
Q4.24
+288703%
86.6M vs -30000
Q1.25
NA
8M vs NA
Return on Equity
QoQ
Q2.23
-7%
-0.07
vs -0.04
Q3.23
-6%
-0.06
vs -0.07
Q4.23
-3%
-0.03
vs -0.06
Q1.24
-5%
-0.05
vs -0.03
Q2.24
-6%
-0.06
vs -0.05
Q3.24
-10%
-0.10
vs -0.06
Q4.24
+19%
0.19
vs -0.10
Q1.25
-15%
-0.15
vs 0.19
Institutionnal Ownership
QoQ
Q4.20
62
62
vs NA
NA
Q1.21
67
67
vs 62
8%
Q2.21
77
77
vs 67
15%
Q3.21
76
76
vs 77
-1%
Q4.21
72
72
vs 76
-5%
Q1.22
70
70
vs 72
-3%
Q2.22
69
69
vs 70
-1%
Q3.22
62
62
vs 69
-10%
proactiveinvestors.co.uk
3 hours ago
prnewswire.com
9 hours ago
prnewswire.com
9 hours ago
benzinga.com
11 hours ago
geekwire.com
19 hours ago
pennystocks.com
20 hours ago
Quote Panel
Key Metrics
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Hold
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
NASDAQ
0.06 ( 1.03%)
Relative Strenght
Volume Buzz
-32%
Earning Acce
No
Dist 52w H.
22%Relative Strength
SBTX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How SBTX compares to sector?
SBTX
-104x